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Selenomethionine incorporation is a powerful technique for assigning sequence
to regions of electron density at low resolution. Genetic introduction of
methionine point mutations and the subsequent preparation and crystallization
of selenomethionyl derivatives permits unambiguous sequence assignment by
enabling the placement of the anomalous scatterers (Se atoms) thus introduced.
Here, the use of this approach in the assignment of sequence in a part of the AP2
clathrin adaptor complex that is responsible for clathrin binding is described.
AP2 plays a pivotal role in clathrin-mediated endocytosis, a tightly regulated
process in which cell-surface transmembrane proteins are internalized from the
plasma membrane by incorporation into lipid-enclosed transport vesicles. AP2
binds cargo destined for internalization and recruits clathrin, a large trimeric
protein that helps to deform the membrane to produce the transport vesicle.
By selenomethionine labelling of point mutants, it was shown that the clathrin-
binding site is buried within a deep cleft of the AP2 complex. A membrane-
stimulated conformational change in AP2 releases the clathrin-binding site from
autoinhibition, thereby linking clathrin recruitment to membrane localization.
1. Introduction
Eukaryotic cells contain a plethora of specialized lipid
membrane-enclosed organelles. Transmembrane proteins
(and often their luminal cargo) are transported between these
organelles in a controlled fashion to ensure the correct func-
tioning of the cell. For example, activated cell surface recep-
tors are often downregulated by internalization from the
plasma membrane and delivery to lysosomes, where they are
degraded. Transmembrane-protein ‘cargo’ is moved between
organelles by incorporation into small membrane-bound
transport containers termed ‘vesicles’ that bud off one orga-
nelle and are transported to and fuse with a second (desti-
nation) organelle. This process has to be tightly regulated to
ensure that proteins are delivered in a timely and accurate
manner. Thus, eukaryotes have evolved a modular trafficking
system in which transmembrane proteins and organelles are
marked with signals that interact with the cytosolic proteins
that control inter-organelle traffic (Traub, 2009).
Cell surface receptors are often marked by the presence
of short, linear amino-acid trafficking motifs; likewise, the
internal leaflet of the plasma membrane is itself marked by the
presence of the phosphoinositide PtdIns(4,5)P2. Specialized
trafficking adaptor proteins termed ‘clathrin adaptors’,
targeted to the plasma membrane by interactions with
PtdIns(4,5)P2, recognize and bind these trafficking motifs
whilst simultaneously recruiting the large trimeric protein
clathrin (Owen et al., 2004). In this way, clathrin adaptors
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sequester transmembrane-protein cargo destined for removal
from the plasma membrane into nascent bud-like structures
coated with clathrin, which polymerizes and drives the
formation of a curved bud or ‘pit’. Ultimately, the clathrin-
coated bud is pinched off the membrane for delivery to
internal compartments.
The major clathrin adaptor present at the plasma
membrane is the assembly polypeptide 2 (AP2) complex. AP2
binds two commonly found internalization motifs [Yxx’,
where ’ denotes a bulky hydrophic residue, and (DE)xxx-
L(LI); Bonifacino & Traub, 2003]. AP2 is a large (300 kDa)
heterotetrameric complex comprising large  and 2 subunits,
a medium 2 subunit and a small 2 subunit. The N-terminal
‘trunk’ regions of  and 2, together with 2 and 2, form
the globular ‘core’ of the complex (Collins et al., 2002; Fig. 1a)
that binds both the Yxx’ and (DE)xxxL(LI) motifs and
PtdIns(4,5)P2. The C-terminal ‘appendage’ domains of  and
2 are separated from the core by flexible (largely unstruc-
tured) ‘hinges’ (Heuser & Keen, 1988). Structural and
biochemical studies of the AP2 core in our laboratory employ
AP2 expressed in Escherichia coli from a pair of plasmids, one
encoding a C-terminally GST-tagged  trunk domain and the
whole 2 subunit and the other encoding an N-terminally
hexahistidine-tagged 2 trunk domain and the whole of the 2
subunit (Fig. 1b), and purified sequentially by GSH and Ni–
NTA affinity chromatography (Collins et al., 2002).
The AP2 core exists in two different conformational states
(Jackson et al., 2010; Fig. 1c). In the ‘locked’ or inactive,
cytosolic state (Fig. 1c, left) the internalization motif-binding
sites are blocked by residues of the 2 subunit and the
PtdIns(4,5)P2-binding sites are on different faces of the
complex. In the ‘open’ or active state all of the known ligand-
binding sites are coplanar (Jackson et al., 2010; Fig. 1c, right).
The conformational change from the locked to the open state
is driven by binding to membranes containing PtdIns(4,5)P2
and stabilized by binding to cargo that contains the correct
internalization motifs. Thus, AP2 acts as a membrane-
activated switch (driven by coincidence detection) that
prevents cargo recognition except at the plasma membrane.
AP2 also binds and recruits clathrin to sites of coated pit
initiation. Clathrin binds AP2 at two sites: a short ‘clathrin-
box’ motif (LLNLD) in the unstructured hinge of 2 binds the
clathrin N-terminal -propeller
domain and a second site on the
C-terminal 2 appendage sub-
domain binds the clathrin ‘leg’,
although binding at this second
site is significantly weaker (Owen
et al., 2000). Biochemical
evidence in our laboratory
suggested that clathrin binding
by AP2 is regulated similarly to
cargo binding, such that clathrin
recruitment was stimulated by
the simultaneous binding of
membrane-localized PtdIns(4,5)P2
and cargo, whereas clathrin
binding was poor in the absence
of such signals (Kelly et al., 2014).
2. Crystallization of an
extended AP2 core
To investigate this observation,
we attempted to crystallize a form
of the AP2 complex comprising
the whole of the 2 subunit (and
thus both clathrin-interacting
sites) along with the 2 and 2
subunits and the trunk sub-
domain of . Unfortunately, we
were unable to crystallize this
complex. Next, we constructed a
version of the AP2 core complex
extended to include a 68-residue
part of the unstructured 2 hinge
(including the clathrin-box motif;
Fig. 2f), which we termed
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Figure 1
(a) Schematic representation of the AP2 clathrin adaptor. The ‘core’ is indicated; the  and 2 hinge and
appendage subdomains are shown in paler colours to indicate the fact that they do not form part of the core.
Note that 2 is composed of an N-terminal longin-fold subdomain and a C-terminal ‘-homology’
subdomain. (b) Schematics of the AP2 constructs used to express recombinant AP2 core in E. coli, showing
the C-terminally GST-tagged  trunk subdomain, the N-terminally hexahistidine-tagged 2 trunk
subdomain and the 2 and 2 subunits. (c) Conformational states of the AP2 core. ‘Locked’ AP2 (PDB
entry 2vgl; Collins et al., 2002) is unable to bind cargo owing to steric blockage of the binding sites by the 2
subunit. Upon plasma-membrane recruitment [driven by association with PtdIns(4,5)P2], the complex
undergoes a conformational change that reveals the cargo-binding sites, allowing cargo recruitment and
stabilization of the ‘open’ conformation (PDB entry 2xa7; Jackson et al., 2010).
hingeHis6.AP2. The extended 2 subunit in our
hingeHis6.AP2 construct ended at Met650, whereas the 2
subunit that we had previously used to determine the core
structure ended at residue Lys591 and the last ordered residue
discernible in the core structure was Val582. We were
concerned that the unstructured segment of the 2 hinge
might be prone to proteolysis. We therefore moved the
hexahistidine tag to the C-terminus of 2 in an attempt to
ensure that only AP2 complexes containing full-length 2 (i.e.
trunk plus hinge fragment) are bound during the Ni–NTA
purification step. This extended 2 subunit construct was
successfully crystallized in the same conditions that were
previously used to grow crystals of the AP2 core in the locked
(inactive) conformational state (Collins et al., 2002).
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Figure 2
(a) Surface representation of the hingeHis6.AP2 ‘extended core’ complex, coloured as in Fig. 1 but in paler shades for clarity. Shown in yellow is the
positive mFo DFc difference density in the ‘bowl’ after restrained refinement of the locked AP2 core structure lacking the hinge fragment (PDB entry
2vgl) against the hingeHis6.AP2 data. (b) Cutaway of the same view of the complex as in (a), showing the buried difference density deep in the ‘bowl’.
(c–e) mFo  DFc maps (contoured at 3, positive density in green and negative density in red) after restrained refinement of the locked AP2 core
structure (PDB entry 2vgl) against the hingeHis6.AP2 data (c) and against data obtained from constructs with 2 subunits truncated at Leu636 (d) and
Gln619 (e). The appropriate 2 subunit is shown schematically beneath each map. ( f ) C-terminal sequences of the 2 constructs depicted in (c), (d) and
(e), starting at the first disordered residue of the 2 hinge region and with the clathrin-box motif underlined.
Crystals were grown at 16C from a mixture of 15 mg ml1
AP2 with 1 mg ml1 IP6 [d-myo-inositol 1,2,3,4,5,6-hexakis-
phosphate; Calbiochem; an analogue of PtdIns(4,5)P2] by
hanging-drop vapour diffusion against a reservoir consisting of
18% PEG 1000, 100 mM sodium/potassium phosphate pH 6.2,
200 mM NaCl, 4 mM DTT. Crystals were cryoprotected in
mother liquor augmented with 20% glycerol and 1 mg ml1
IP6 and cryocooled by plunging into liquid N2. Data were
collected at 100 K on beamline I03 at Diamond Light Source
(DLS). The crystals belonged to space group P3121, with unit-
cell parameters a = 122, c= 259 A˚,
and typically diffracted to around
2.8 A˚ resolution overall. Data
were integrated, scaled and
merged with XDS, XSCALE
(Kabsch, 2010) and SCALA
(Evans, 2006) using the auto-
mated data-processing package
xia2 (Winter, 2010). A summary
of the crystallographic data is
presented in Table 1.
Since the crystals were
isomorphous to crystals of the
AP2 core in the locked confor-
mation, the structure of the
locked AP2 core (PDB entry
2vgl; Collins et al., 2002) was
refined against the new data with
REFMAC5 (Murshudov et al.,
2011) using TLS and restrained
refinement. When AP2 transi-
tions from the locked to the open
conformation, the alpha sole-
noids of the  and 2 trunk
subdomains flex around several
hinge points (Jackson et al., 2010),
defining a set of rigid subdomains
that we used as TLS groups in
the refinement of the new AP2
locked-core structure. After
initial refinement, a difference
electron-density (mFo  DFc)
map suggested additional, unmo-
delled electron density buried in a
deep cleft of the core that we
term the ‘bowl’ of AP2 (Figs. 2a
and 2b). This region of electron
density was disconnected from
the rest of the core and we were
unable to discern side chains that
might allow us to positively
identify the buried residues.
Given the presence of the
clathrin-box motif in the segment
of the 2 hinge included in our
extended AP2 construct, and
given our biochemical observa-
tions suggesting that the locked
conformation of AP2 was unable
to bind clathrin efficiently, it
became important to determine
exactly which part of the hinge
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Figure 3
(a) Residues (highlighted in gold) chosen for single-site mutagenesis to methionine in the 2 hinge. The
clathrin-box motif is underlined. (b, c) Mass spectra of the 2 subunit of native (a) and selenomethionyl (b)
‘wild-type’ hingeHis6.AP2. The masses of major peaks are shown. (d–g) Final 2mFo  DFc maps in the
hinge region (contoured at 0.34 e A˚3) with overlaid hinge models showing residues mutated to
methionine along with selenium sites (shown as gold balls) found in the appropriate data sets, indicating
good agreement between the sites and the hinge model.
was buried in the bowl. If it transpired that the clathrin-box
motif itself, or a closely flanking region, was buried in the bowl
then this would provide a plausible structural mechanism to
reduce inappropriate clathrin binding and, potentially, link
clathrin recruitment to a membrane-stimulated conforma-
tional change.
3. Truncation-mutant analysis
To begin to narrow down the buried region, we constructed
mutants of hingeHis6.AP2 truncated after Gln619 and
Leu636 (Fig. 2f) and lacking the C-terminal hexahistidine tag
to avoid the possibility of the tag interfering with binding in
the bowl. These mutants were expressed and crystallized as
described above, yielding crystals that were isomorphous to
those of the nontruncated complex. Refinement of the AP2
core complex structure against these data revealed that the
Leu636 truncation mutant retained the unmodelled difference
density in the bowl (Fig. 2d), whereas the Gln619 truncation
mutant did not (Fig. 2e). This suggested that the buried
sequence was N-terminal to Leu636 and might lie between
Gln619 and Leu636. On this basis, we prepared preliminary
models that placed the region between residues 619 and 636
into the difference electron density visible in the bowl.
Secondary-structure prediction using the JPred server (Cole et
al., 2008) suggested the presence of a short region of helix
spanning Asp626–Leu631. At low contour levels, a 2mFoDFc
map hinted at a possible helical region in the buried electron
density; as a result, our first model was built on this basis. The
occupancy of the buried fragment when refined with fixed B
factors in REFMAC5 was 0.8. We then prepared a series of
models sequentially shifted by one residue at a time. The
quality of the electron density was, however, insufficient to
differentiate between these models. Similarly to all AP2
structures determined to date, the 2 subunit is less well
ordered than the  subunit or the N-terminal regions of the 
subunit abutting , probably because 2 acts as a ‘latch’ to
hold the complex shut and is thus poised to swing away from 
and 2 in order to reveal the cargo-binding sites (Jackson et
al., 2010). It is therefore not surprising that the buried portion
of the 2 hinge is likewise comparatively poorly ordered,
rendering definitive identification of the residues problematic.
It remained possible that the buried region lay partly or
wholly N-terminal to Gln619 and that the removal of residues
619–636 destabilized the hinge–bowl interaction perhaps
owing to a loss of weaker, secondary interactions. Thus, we
sought a way to identify the buried residues definitively.
4. Analysis of (seleno)methionine point mutants
Others have successfully used methionine point mutants
incorporating selenomethionine (SeMet) to identify regions of
structure in low-resolution maps (Pomeranz Krummel et al.,
2009; Oubridge et al., 2009) or for chain tracing (Evans, 2003).
We decided to pursue a similar strategy to identify the residues
buried in the bowl of AP2. Apart from two methionine resi-
dues at the extreme C-terminus, the 2 hinge fragment in our
construct lacks endogenous methionines (Fig. 2f). We there-
fore constructed a series of point mutants in which single
residues were substituted with methionine (Fig. 3a). Initially,
we chose hydrophobic residues (valine, isoleucine and
leucine) together with glutamine or glutamate residues (which
contain an aliphatic side chain similar in length to methionine)
to mutate. We subsequently mutated a single aspartate in
order to bridge a gap of three residues between neighbouring
mutation sites. By crystallizing each mutant and pinpointing
selenium sites, we hoped to determine the position of the
single introduced methionine in each case and thereby trace
the residues buried in the bowl.
Initial attempts to express ‘wild-type’ hingeHis6.AP2
using a methionine-auxotroph strain (B834) grown in minimal
medium supplemented with selenomethionine were unsuc-
cessful. We therefore attempted to employ a methionine-
biosynthesis pathway inhibition approach (Van Duyne et al.,
1993). In this technique, the endogenous E. coli methionine-
biosynthetic pathway is suppressed by the addition of a
cocktail of amino acids that cause product inhibition of key
enzymes in the pathway, while the minimal growth medium
is supplemented with selenomethionine. This approach also
initially failed to produce AP2. We next attempted to ‘kick-
start’ the expression of AP2 by supplementing the minimal
growth medium with some rich broth (25%). This approach
proved quite successful insofar as crystallographically useful
quantities of purified AP2 were produced. To estimate the
efficiency of selenomethionine incorporation, we analyzed
both native and selenomethionyl ‘wild-type’ hingeHis6.AP2
by electrospray mass spectrometry using a Waters Micromass
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Table 1
Crystallographic data for hingeHis6.AP2.
Values in parentheses are for the highest resolution bin.
Data collection
Resolution range (A˚) 97.37–2.79 (2.86–2.79)
Beamline I03, DLS






Mean I/(I) 21.9 (3.2)
Completeness (%) 99.93 (100)
Multiplicity 10.9 (11.2)
Wilson B factor (A˚2) 85.56
CC1/2 0.999 (0.859)
CC* 1.000 (0.961)
Total reflections 604922 (61719)
Unique reflections 55666 (5521)
Space group P3121
Unit-cell parameters (A˚) a = b = 121.3, c = 259.4
Refinement
R/Rfree 0.2034/0.2594
No. of non-H atoms 13889
Average B factor (A˚2) 83.8
Ramachandran favoured (%) 93.0
Ramachandran outliers (%) 1.0
R.m.s.d., bond lengths (A˚) 0.013
R.m.s.d., bond angles () 1.54
Clashscore† 10.34
† As defined in Chen et al. (2010).
LCT (Figs. 3b and 3c). With the native protein, a strong peak
was found at approximately the expected molecular weight
of the 2 subunit (expected mass 50 971 Da; observed mass
50 983 Da; Fig. 3b); a peak was also found for the 2 subunit,
although the mass spectrum was noisier. Strong peaks corre-
sponding to the  and 2 subunits were not found; however,
since all four subunits are coexpressed in the same bacterial
cells, we assume that the labelling efficiency for 2 is repre-
sentative of the whole complex. With the selenomethionyl
protein, mass spectrometry revealed a series of peaks
approximately normally distributed around a central peak
corresponding to a 2 subunit with a mass of 51 263 Da
(280 Da greater than the native protein; Fig. 3c). The mean
separation between the peaks is 45.7 Da, which is close to the
expected difference in molecular mass between sulfur and
selenium (47 Da); thus, the observed peaks correspond to
proteins differing by a single substituted selenomethionine.
The 280 Da difference in mass between the main peaks of the
native and selenomethionyl proteins suggests an incorporation
efficiency of 45% in the 14 methionine residues of 2. We
therefore estimated the overall incorporation efficiency to be
45%.
Selenomethionyl derivatives of wild-type and mutant
hingeHis6.AP2 were produced and crystallized. Two mutants
failed to crystallize in initial attempts (E616M and I621M) and
were not investigated further. Most crystallized in the same
conditions and with the same space group and unit-cell
parameters as the wild-type hingeHis6.AP2 complex. In
practice, we find that crystals of AP2 vary greatly in the extent
of their diffraction despite uniformity of gross morphology,
and individual large AP2 crystals may diffract non-uniformly
across the crystal volume. Thus, we routinely screened both
multiple crystals and multiple positions within larger single
crystals to maximize our chances of obtaining the best possible
diffraction data. In the case of the selenomethionyl derivatives
the best crystals diffracted to around 3 A˚ resolution. Data
were collected at a wavelength of 0.98 A˚ (0.91 A˚ in some
cases owing to the constraints of beamline availability) on
beamlines I02, I03 and I04-1 at DLS. In all cases we sought
to maximize anomalous multiplicity in order to improve the
accuracy in measurement of anomalous differences, whilst
avoiding excessive radiation damage. Data sets were collected
from crystals diffracting to better than 3.5 A˚ resolution. We
collected multiple data sets for each mutant (typically three,
but ranging from one to eight). Data were integrated, scaled
and merged with XDS, XSCALE (Kabsch, 2010) and
AIMLESS (Evans & Murshudov, 2013), using the automated
data-processing package xia2 (Winter, 2010) and custom
scripts to automate processing of all selenomethionyl mutant
data sets. In some cases, two data sets were merged in order to
improve the accuracy of anomalous signal measurement (Liu
et al., 2011). Consistent indexing was enforced by specifying a
reference data set in xia2. This was necessary because there
are two valid axis definitions in P3121 (related by the operator
h, k, l).
5. Location of selenium sites by anomalous
log-likelihood gradient map completion
In almost all cases the anomalous signal was quite weak, with
useful signal generally not extending beyond 6 A˚ resolution
(as judged by the resolution at which the ratio of anomalous
differences to their estimated standard deviations drops below
1.3; Schneider & Sheldrick, 2002; Fig. 4). In the absence of
any other phase information, this would make substructure
solution difficult, and indeed attempts to solve the substruc-
ture with SHELXD (Schneider & Sheldrick, 2002) failed with
all but one of the mutant data sets (D626M). Given the low
incorporation of selenomethionine (45%) and the large
number of selenomethionine sites (38 in the core), this is not
surprising. However, our goal was not to solve the structure
using experimental phases, but rather to identify selenium
marker sites. Therefore, we could make use of this weak
anomalous data to find sites by using phases calculated from
our existing AP2 locked-core model. Our strategy was to
identify anomalous scatterers (i.e. selenium sites) by iterative
substructure completion using anomalous log-likelihood
gradient maps with Phaser-EP, where starting phases were
provided by an AP2 model refined against the new data and
including a ‘best-guess’ model of the buried hinge fragment. In
this approach, SAD log-likelihood gradient maps are searched
for sites where the addition of an anomalous scatterer would
improve the fit of the anomalous scattering model to the
experimental data and, after new sites have been identified,
the process is iterated until the map is ‘flat’ (Read & McCoy,
2011). The likelihood formulation has the advantage of
increased sensitivity compared with simple difference Fouriers
(de La Fortelle & Bricogne, 1997). We used custom scripts to
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Figure 4
Anomalous differences as a function of resolution for native and four
selenomethionyl mutant data sets calculated by SHELXC. The mean
ratio of anomalous differences to their estimated standard deviation (d0 0/
; vertical axis) is plotted against dmin (resolution at the midpoint of the
bin; horizontal axis). Except for the D626M data set, significant d0 0/
(above 1.3; Schneider & Sheldrick, 2002) is not present beyond 6 A˚
resolution. The Q619M and D626M data sets are two-crystal merged data
sets; Q624M and L632M are single data sets. Note that the D626M data
set, which displays noticeably better anomalous signal, was the only one
of these data sets for which the anomalous substructure could be solved
using SHELXD.
automate the substructure completion with Phaser-EP. The
Z-score cutoff for addition of new sites was set at the default
level of 6.
In the case of the wild-type hingeHis6.AP2, selenium sites
corresponding to the ‘core’ methionines (i.e. methionines in
the previously solved AP2 core) were found, including several
that most likely represented alternative methionine confor-
mers; no additional sites that might correspond to the
C-terminal pair of methionines (Fig. 2f) were found. The
methionine point mutant hingeHis6.AP2 complexes yielded
similar results, except that in four of the mutants (Q619M,
Q624M, D626M and L632M) a single selenium site distinct
from the ‘core’ methionine positions was found in the bowl
(Figs. 3d, 3e, 3f and 3g) close to the unmodelled difference
density. A summary of crystallographic data for these mutants
is presented in Table 2. In all cases the anomalous site within
the bowl was the highest peak that could not be attributed
to a methionine residue within the AP2 core structure. An
example of the sites found by Phaser-EP over the course of
several cycles of substructure completion is shown in Fig. 5.
Since the sites present in the bowl could not be explained by
any of the core methionines, we attributed them to the single
methionine mutations introduced into each mutant. Based
on our preliminary model for the buried hinge fragment, the
spacing between these selenium sites was consistent with the
spacing between the residues mutated to methionine in these
mutants. This allowed us to fix the register and directionality
of the hinge residues, showing that the clathrin-box motif is
indeed buried in the core and thus inaccessible to clathrin in
this conformation (Fig. 6a). It is interesting to note that JPred
secondary-structure prediction had suggested that residues
Asp626–Leu631 form a short stretch of -helix; based on our
selenomethionine marker strategy, these residues indeed
correspond to a short region that is -helical.
For several mutants (L615M, V620M and L628M) no sele-
nium sites were found in the hinge region. L615M lies outside
the ordered region based on our subsequent model building
(see below); in the case of V620M the overall difference
electron density in the bowl is very poor. For the L628M
mutant only one data set was collected and this did not reveal
a selenium site in the hinge. One mutant, L631M, yielded a site
in the hinge region at a location commensurate with the final
assigned structure, but the Z-score of this site (5) was less
than our cutoff value of 6 for new sites.
In a few cases, selenium sites were found at cysteines in the
relatively rigid and well ordered 2 subunit. We speculate that
these are sites where selenocysteine has been incorporated in
place of cysteine, either because of traces of selenocysteine
present in our selenomethionine stock or perhaps owing to the
salvage of selonocysteine from selenomethionine; however,
unlike mammalian cells, there is no documented methionine-
to-cysteine salvage pathway in E. coli.
The only anomalous scattering site that could not be
attributed to selenomethionine or selenocysteine coincided
with a small unmodelled region of difference electron density.
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Figure 5
Anomalous scattering sites located by Phaser-EP from two merged
Q619M data sets in successive cycles of map completion (cycles indicated
by gaps between sets), showing Z-scores (vertical axis) for each site. Blue
bars indicate ‘core’ methionines, the gold bar indicates the hinge site
ascribed to the methionine point mutant (Q619M), grey bars indicate
‘core’ methionine alternative conformations and the green bar was
interpreted as a chloride ion.
Table 2
Crystallographic data for selenomethionyl hingeHis6.AP2 mutants.
Values in parentheses are for the highest resolution bin.
Q619M SeMet Q624M SeMet D626M SeMet L632M SeMet
Resolution range (A˚) 60.8–3.1 (3.15–3.07) 66.9–3.2 (3.29–3.21) 64.5–3.2 (3.24–3.16) 86.2–3.3 (3.33–3.25)
Beamline I03, DLS I04-1, DLS I02, DLS I04-1, DLS
No. of crystals 2 1 2 1
Wavelength (A˚) 0.9762 0.9795 0.9795 0.9173
Rmerge 0.155 (0.725) 0.113 (0.742) 0.127 (0.886) 0.134 (0.841)
Rmeas (within I
+/I) 0.158 (0.157) 0.131 (0.125) 0.138 (0.131) 0.138 (0.137)
Rp.i.m. (within I
+/I) 0.027 (0.036) 0.040 (0.053) 0.025 (0.032) 0.031 (0.042)
Mean I/(I) 31 (4.5) 15.5 (3.3) 29.9 (4.4) 21.7 (4.5)
Completeness (%) 100.0 (100.0) 99.8 (99.8) 100.0 (100.0) 100.0 (100.0)
Multiplicity 35 (28.1) 10.5 (11.2) 31.1 (22.5) 20.1 (21.5)
Anomalous completeness (%) 100.0 (100.0) 99.8 (99.8) 100.0 (100.0) 100.0 (100.0)
Anomalous multiplicity 18.3 (14.4) 5.5 (5.8) 16.3 (11.7) 10.6 (11.1)
anom correlation (half data sets) 0.408 0.348 0.808 0.135
Anomalous normal probability slope 1.114 1.211 1.470 1.058
Total reflections 1480736 389509 1200576 718549
Total unique reflections 42274 36952 38649 35814
We ascribed this to a chloride ion because of its electron-dense
nature (the B factor of a water molecule placed at this position
refined to an unrealistically low value) and because of the
presence of two backbone N atoms and one O atom within
3.5 A˚ (corresponding to the first coordination sphere;
Carugo, 2014). Chlorine has an f 00 of 0.3 electrons at the
selenium edge, compared with 3.8 electrons for selenium,
but we estimated the Se incorporation to be only 0.45 (Fig.
3). Thus, it is plausible that a well ordered chloride ion with an
occupancy of one might cause an anomalous peak height of
about a fifth the size of a selenium and thus be found as a weak
site in our analysis.
The selenium sites found in the bowl of the four point
mutants are ‘weak’ compared with the majority of sites attri-
butable to core methionines. This is consistent with the notion
of a partially buried hinge fragment, since tight binding would
preclude rather than reduce clathrin binding to AP2. Since we
were able to match four selenium sites with their expected
positions based on our model, and given the lack of ‘spurious’
sites that could not be attributed to methionine residues (or in
rare cases to cysteines or a halide ion), we were confident in
our assignment of the hinge sequence.
6. Final model building, refinement and biological
implications
The model was refined by iterative rounds of rebuilding in
Coot (Emsley et al., 2010) and TLS and restrained refinement
in REFMAC5. MolProbity (Chen et al., 2010), accessed via the
PHENIX interface (Echols et al., 2012), and the validation
tools within Coot were consulted throughout the refinement
process. The final model had R and Rfree residuals of 0.203 and
0.259, respectively, and good stereochemistry (r.m.s.d.s of
0.013 A˚ for bond lengths and 1.54 for bond angles; Table 1).
In common with the original AP2 core structure (Collins et al.,
2002), the helical solenoid of the 2 trunk is followed by a
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Figure 6
(a) Overall (left) and close-up (right) views of the structure of hingeHis6.AP2 (PDB entry 4uqi). The residues of the hinge resolved in the structure are
shown in green as a stick representation. The AP2 core is depicted as a surface representation coloured as in Fig. 1. The residues of the buried hinge are
indicated in the close-up view, with electron density shown as a mesh (2mFo  DFc map contoured at 0.34 e A˚3). Also shown are the positions of the
selenium sites found in the bowl for each of the methionine mutants indicated, showing good agreement with the positions of the corresponding wild-
type residues that were mutated. (b, c) Views of the hinge-binding site in the locked (b) and open (c) conformational states; in the ‘open’ state (c), the
hinge residues from the ‘locked’ state hingeH6.AP2 structure are superposed onto the ‘open’ structure and shown in grey. Adapted from Kelly et al.
(2014).
stretch of extended peptide and a trio of short helices that
pack against each other and against the 2 trunk; after Val582
the hinge becomes disordered. Our new structure (Fig. 6a)
reveals that after 35 disordered residues, the 2 hinge then
loops back in towards the bowl of AP2, forming a short stretch
of -sheet with a loop between two helices of the -subunit
solenoid; there follows a turn and an -helix that includes the
first few residues of the clathrin-box motif before the electron
density is lost.
Alignment of the open AP2 conformation with our new
extended AP2 locked conformation allowed us to propose a
mechanism for the regulation of clathrin binding. The two
structures were aligned on the rigid regions of structure
proximal to the buried hinge fragment (residues 480–510 of
the  subdomain; Figs. 6b and 6c). In the open conformation
the entrance to the bowl from this side of the complex
collapses, blocking the entry point of the hinge (Fig. 6c). Thus,
in the open conformation the 2 hinge must be released from
the bowl, allowing clathrin to bind. This model (Fig. 7)
explained our biochemical observation that clathrin recruit-
ment and polymerization is stimulated by the binding of AP2
to a PtdIns(4,5)P2- and cargo-containing membrane.
Interestingly, the related clathrin adaptor AP1, which
mediates trafficking between certain internal compartments
(trans-Golgi network and endosomes), undergoes similar
conformational rearrangements upon membrane localization,
albeit driven by binding to the membrane-bound small
GTPase Arf1 (Ren et al., 2013) rather than to PtdIns(4,5)P2.
The hinge of the AP1 1 subunit (equivalent to 2 in AP2)
contains a similar clathrin-box motif and flanking sequence
(Kelly et al., 2014). It remains to be seen whether or not
clathrin recruitment by AP1 is regulated similarly to AP2.
7. Conclusions
Our studies have shown that useful information can be
obtained from partial selenomethionine-incorporation
strategies when full incorporation is prohibited owing to
problems with protein production. Although it was necessary
to screen multiple crystals or sites on large crystals in order to
obtain the best diffraction and anomalous signal, this is now a
practical approach because of improvements in synchrotron
beamlines and X-ray diffraction detectors that have dramati-
cally increased the speed of data collection. Our crystal-
lographic studies provided a structural framework to design
biochemical experiments that elucidated how AP2 keeps its
clathrin-binding motif hidden from clathrin until it is correctly
localized at the plasma membrane and bound to cargo (Kelly
et al., 2014).
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